LEO Pharma Investigational Site

Waterloo, Ontario N2J 1C4

2 studies enrolling now · 3 studies all time

What they study most

Atopic Dermatitis, Lichen Sclerosus, Palmoplantar Pustulosis

Studies at this site

• A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus — Recruiting now
• A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis — Recruiting now
• Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND — Completed